Literature DB >> 1825262

Age-related patterns of thyroid-stimulating hormone response to thyrotropin-releasing hormone stimulation in Down syndrome.

T Sharav1, H Landau, Z Zadik, T R Einarson.   

Abstract

Thyroid function in subjects with Down syndrome was studied using the thyrotropin-releasing hormone test. Forty-seven infants and children with Down syndrome were investigated. Ages ranged from 1 month to 7 years; there were 26 boys and 21 girls. Fourteen of the subjects with Down syndrome who had an exaggerated thyroid-stimulating hormone response to thyrotropin-releasing hormone stimulation had two or more annual follow-up tests. The remaining 33 subjects who only underwent one thyrotropin-releasing hormone test were compared with 22 age-matched controls (11 boys and 11 girls). Mean basal thyroxine 4 and triiodothyronine 3 values were in the normal ranges. All thyroid antibody titers were negative. Mean basal thyroid-stimulating hormone levels of subjects with Down syndrome were significantly higher than those of controls for all ages, even though there was a decline in thyroid-stimulating hormone levels in both groups. Peak thyroid-stimulating hormone response levels were significantly greater in the subjects with Down syndrome than in the controls. Longitudinal study of the 14 children with Down syndrome with an exaggerated thyroid-stimulating hormone response showed that the response remained exaggerated until the third year of life, when it declined to normal levels. Thyroid dysfunction during the growth spurt of infancy or delayed maturation of the hypothalamic pituitary thyroid axis are proposed mechanisms.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1825262     DOI: 10.1001/archpedi.1991.02160020064018

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  7 in total

1.  Unusual thyroid constellation in Down syndrome: congenital hypothyroidism, Graves' disease, and hemiagenesis in the same child.

Authors:  Todd D Nebesio; Erica A Eugster
Journal:  J Pediatr Endocrinol Metab       Date:  2009-03       Impact factor: 1.634

2.  Natural course of subclinical hypothyroidism in Down's syndrome: prospective study results and therapeutic considerations.

Authors:  D Rubello; G B Pozzan; D Casara; M E Girelli; S Boccato; F Rigon; C Baccichetti; M Piccolo; C Betterle; B Busnardo
Journal:  J Endocrinol Invest       Date:  1995-01       Impact factor: 4.256

Review 3.  Endocrine and musculoskeletal abnormalities in patients with Down syndrome.

Authors:  Yousra Hawli; Mona Nasrallah; Ghada El-Hajj Fuleihan
Journal:  Nat Rev Endocrinol       Date:  2009-06       Impact factor: 43.330

4.  TSH receptor and Gs(alpha) genetic analysis in children with Down's syndrome and subclinical hypothyroidism.

Authors:  M Tonacchera; A Perri; G De Marco; P Agretti; L Montanelli; M E Banco; A Corrias; J Bellone; M T Tosi; P Vitti; E Martino; A Pinchera; L Chiovato
Journal:  J Endocrinol Invest       Date:  2003-10       Impact factor: 4.256

5.  Subclinical hypothyroidism in paediatric population treated with levothyroxine: a real-world study on 2001-2014 Italian administrative data.

Authors:  Nella Augusta Greggio; Elisa Rossi; Silvia Calabria; Alice Meneghin; Joaquin Gutierrez de Rubalcava; Carlo Piccinni; Antonella Pedrini
Journal:  Endocr Connect       Date:  2017-06-14       Impact factor: 3.335

Review 6.  Thyroid Disorders in Subjects with Down Syndrome: An Update.

Authors:  Nermine H Amr
Journal:  Acta Biomed       Date:  2018-03-27

7.  Subclinical Hypothyroidism as the Most Common Thyroid Dysfunction Status in Children With Down's Syndrome.

Authors:  Kamila Szeliga; Aleksandra Antosz; Karolina Skrzynska; Barbara Kalina-Faska; Aleksandra Januszek-Trzciakowska; Aneta Gawlik
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-04       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.